United Maritime Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,000
Closed -$236K 65
2021
Q4
$236K Buy
+4,000
New +$198K 0.27% 53
2021
Q3
Sell
-6,450
Closed -$253K 88
2021
Q2
$253K Sell
6,450
-800
-11% -$31.1K 0.19% 64
2021
Q1
$263K Buy
7,250
+400
+6% +$14.2K 0.22% 59
2020
Q4
$252K Buy
+6,850
New +$251K 0.22% 54

Other funds holding PFE

United Maritime Capital's PFE Position: Q1 2022 in Review

United Maritime Capital sold out of Pfizer (PFE) in Q1 2022, closing a stake of 4,000 shares — an estimated $236K sold.

United Maritime Capital first reported a position in PFE in Q4 2020 and held it in 4 quarters. The position peaked at $263K in Q1 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • United Maritime Capital reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • United Maritime Capital sold 4,000 Pfizer shares in Q1 2022, an estimated $236K.
  • United Maritime Capital first reported a position in Pfizer in Q4 2020 and held it in 4 quarters.
  • United Maritime Capital's Pfizer position peaked at $263K in Q1 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on United Maritime Capital's 13F filing for Q1 2022, filed 12 May 2022.